Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBITDA
-26.53 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Biomarin Pharmaceutical Inc's enterprise value is $13,780 Mil. Biomarin Pharmaceutical Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $-519 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBITDA ratio for today is -26.53.

BMRN' s EV/EBITDA Range Over the Past 10 Years
Min: -25504   Max: 1532.3
Current: -26.53

-25504
1532.3

During the past 13 years, the highest EV/EBITDA Ratio of Biomarin Pharmaceutical Inc was 1532.30. The lowest was -25504.00. And the median was -74.60.

BMRN's EV/EBITDA is ranked lower than
99.99% of the 346 Companies
in the Global Biotechnology industry.

( Industry Median: 16.98 vs. BMRN: -26.53 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Biomarin Pharmaceutical Inc's stock price is $82.21. Biomarin Pharmaceutical Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $-2.96. Therefore, Biomarin Pharmaceutical Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Biomarin Pharmaceutical Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=13779.870/-519.46
=-26.53

Biomarin Pharmaceutical Inc's current Enterprise Value is $13,780 Mil.
Biomarin Pharmaceutical Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was 86.69 (Dec. 2015 ) + -59.039 (Mar. 2016 ) + -518.587 (Jun. 2016 ) + -28.524 (Sep. 2016 ) = $-519 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Biomarin Pharmaceutical Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=82.21/-2.96
=

Biomarin Pharmaceutical Inc's share price for today is $82.21.
Biomarin Pharmaceutical Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was 0.44 (Dec. 2015 ) + -0.53 (Mar. 2016 ) + -2.61 (Jun. 2016 ) + -0.26 (Sep. 2016 ) = $-2.96.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Biomarin Pharmaceutical Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -101.90-326.1726.4558.82180.64-23,974.95-94.71-81.24-219.12-184.11

Biomarin Pharmaceutical Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -81.97-207.79-219.12-209.15-151.60-72.82-184.11-140.27-22.99-29.89
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK